[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:glaucoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":289,"states":290},"Glaucoma",46,37,[8,15,22,28,34,41,47,53,59,65,72,78,85,91,97,103,109,115,120,126,132,137,143,149,155,161,167,172,178,184,190,196,202,208,214,220,226,232,239,246,252,257,264,270,277,283],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05626426","Electrical Stimulation for the Treatment of Optic Neuropathies",[],"RECRUITING","2026-08-26T02:18:05.435729Z","2026-05-05T02:43:28.986752Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05401357","Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.",[19],"Phase 3","2026-08-26T02:18:14.396999Z","2026-05-05T02:43:28.974098Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06128720","Hyperbaric Oxygen Therapy for Optic Neuropathies",[],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:28.545713Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT05924477","Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial",[],"2026-08-26T02:16:40.941792Z","2026-05-05T02:43:27.835388Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":39,"content_modified":40},"NCT05206877","Topical Insulin for Glaucoma",[38],"Phase 1","2026-08-26T02:16:11.347936Z","2026-05-05T02:43:29.644351Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT03933631","Pilocarpine Use After Kahook Goniotomy",[19],"2026-08-26T02:16:55.892527Z","2026-05-05T02:43:28.742161Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT07218796","Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)",[19],"2026-08-26T02:17:57.997171Z","2026-05-05T02:43:28.121813Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":57,"content_modified":58},"NCT06963684","Glaucoma Laser Assessment of Stability and Sustainability",[],"2026-08-26T02:15:15.642947Z","2026-05-05T02:43:28.115284Z",{"nct_id":60,"title":61,"phases":62,"status":12,"updated_at":63,"content_modified":64},"NCT07218783","Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)",[19],"2026-08-26T02:15:40.343619Z","2026-05-05T02:43:27.627288Z",{"nct_id":66,"title":67,"phases":68,"status":12,"updated_at":70,"content_modified":71},"NCT06593405","The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma",[69],"Early Phase 1","2026-08-26T02:19:29.119921Z","2026-05-05T02:43:27.276992Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":76,"content_modified":77},"NCT03011541","Stem Cell Ophthalmology Treatment Study II",[],"2026-08-26T02:17:33.002248Z","2026-05-05T02:43:29.077392Z",{"nct_id":79,"title":80,"phases":81,"status":12,"updated_at":83,"content_modified":84},"NCT05344274","Retinal Blood Flow and Autoregulation",[82],"Phase 4","2026-08-26T02:17:22.153941Z","2026-05-05T02:43:29.323849Z",{"nct_id":86,"title":87,"phases":88,"status":12,"updated_at":89,"content_modified":90},"NCT06882356","The Glaucoma and Retinopathy Screening Study",[],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:28.731127Z",{"nct_id":92,"title":93,"phases":94,"status":12,"updated_at":95,"content_modified":96},"NCT05150197","Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease",[],"2026-08-26T02:17:03.534765Z","2026-05-05T02:43:28.566783Z",{"nct_id":98,"title":99,"phases":100,"status":12,"updated_at":101,"content_modified":102},"NCT06854198","Glaucoma Screening to Enhance At-Risk Californians' Health",[],"2026-08-26T02:18:08.005333Z","2026-05-05T02:43:27.664592Z",{"nct_id":104,"title":105,"phases":106,"status":12,"updated_at":107,"content_modified":108},"NCT05726058","Ocular Blood Flow Imaging for Glaucoma Assessment",[],"2026-08-26T02:18:45.196599Z","2026-05-05T02:43:27.294145Z",{"nct_id":110,"title":111,"phases":112,"status":12,"updated_at":113,"content_modified":114},"NCT07298356","Automated Applanation Tonometry - Updated",[],"2026-08-26T02:18:34.622081Z","2026-04-29T02:57:57.067244Z",{"nct_id":116,"title":117,"phases":118,"status":12,"updated_at":113,"content_modified":119},"NCT03752840","Village-Integrated Eye Worker Trial II",[],"2026-07-05T05:32:16.771139Z",{"nct_id":121,"title":122,"phases":123,"status":12,"updated_at":124,"content_modified":125},"NCT02157025","A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics",[],"2026-08-26T02:14:59.425132Z","2026-04-29T02:57:57.118527Z",{"nct_id":127,"title":128,"phases":129,"status":12,"updated_at":130,"content_modified":131},"NCT06629649","Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers",[],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:28.814009Z",{"nct_id":133,"title":134,"phases":135,"status":12,"updated_at":124,"content_modified":136},"NCT07510087","Glaucoma Related Quality of Life",[],"2026-05-13T02:55:06.711338Z",{"nct_id":138,"title":139,"phases":140,"status":12,"updated_at":141,"content_modified":142},"NCT07428668","Change in IOP Fluctuation After DSLT",[],"2026-08-26T02:15:26.669629Z","2026-05-13T02:55:06.703469Z",{"nct_id":144,"title":145,"phases":146,"status":12,"updated_at":147,"content_modified":148},"NCT07425496","To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.",[],"2026-08-26T02:15:38.131683Z","2026-05-13T02:55:06.702244Z",{"nct_id":150,"title":151,"phases":152,"status":12,"updated_at":153,"content_modified":154},"NCT06993597","Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy",[],"2026-08-26T02:17:20.511551Z","2026-05-13T02:55:06.604457Z",{"nct_id":156,"title":157,"phases":158,"status":12,"updated_at":159,"content_modified":160},"NCT04354545","Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications",[],"2026-08-26T02:18:16.220328Z","2026-05-13T02:55:06.247023Z",{"nct_id":162,"title":163,"phases":164,"status":12,"updated_at":165,"content_modified":166},"NCT07149740","Data Gathering for A10900",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.660570Z",{"nct_id":168,"title":169,"phases":170,"status":12,"updated_at":153,"content_modified":171},"NCT06139523","Optimize Pediatric OCT Imaging",[],"2026-05-13T02:55:06.419004Z",{"nct_id":173,"title":174,"phases":175,"status":12,"updated_at":176,"content_modified":177},"NCT05414994","Assessment of the Ocular Microbiome in Health and Disease",[],"2026-08-26T02:18:49.989941Z","2026-05-13T02:55:06.347406Z",{"nct_id":179,"title":180,"phases":181,"status":12,"updated_at":182,"content_modified":183},"NCT05685485","Tied Tube Trial in Glaucoma Surgery",[],"2026-08-26T02:19:13.549512Z","2026-05-13T02:55:06.371046Z",{"nct_id":185,"title":186,"phases":187,"status":12,"updated_at":188,"content_modified":189},"NCT00286637","Novel Glaucoma Diagnostics",[],"2026-08-26T02:15:42.447052Z","2026-05-13T02:55:06.033997Z",{"nct_id":191,"title":192,"phases":193,"status":12,"updated_at":194,"content_modified":195},"NCT07588152","Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension",[82],"2026-08-26T02:17:04.346841Z","2026-05-29T15:36:40.198831Z",{"nct_id":197,"title":198,"phases":199,"status":12,"updated_at":200,"content_modified":201},"NCT03400137","IOP Elevation Study",[],"2026-08-26T02:15:09.079045Z","2026-05-05T02:43:29.047345Z",{"nct_id":203,"title":204,"phases":205,"status":12,"updated_at":206,"content_modified":207},"NCT05523622","Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices",[],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:28.648323Z",{"nct_id":209,"title":210,"phases":211,"status":12,"updated_at":212,"content_modified":213},"NCT06124521","Community Based Treatment for (ComBaT) Glaucoma",[],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:27.509460Z",{"nct_id":215,"title":216,"phases":217,"status":12,"updated_at":218,"content_modified":219},"NCT06841575","Advancing Pediatric Retinal Imaging With Auto-aligned OCT",[],"2026-08-26T02:19:02.550788Z","2026-05-05T02:43:28.963801Z",{"nct_id":221,"title":222,"phases":223,"status":12,"updated_at":224,"content_modified":225},"NCT06934577","Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2",[],"2026-08-26T02:16:51.982021Z","2026-05-05T02:43:27.837149Z",{"nct_id":227,"title":228,"phases":229,"status":12,"updated_at":230,"content_modified":231},"NCT06943599","Strategies for Improving Linkage-to-Care After Eye Disease Screening",[],"2026-08-26T02:16:50.548894Z","2026-04-29T02:57:57.107389Z",{"nct_id":233,"title":234,"phases":235,"status":236,"updated_at":237,"content_modified":238},"NCT07174401","Rocklatan Retinal Perfusion OCT Study",[82],"NOT_YET_RECRUITING","2026-08-26T02:15:25.633039Z","2026-05-05T02:43:28.835393Z",{"nct_id":240,"title":241,"phases":242,"status":236,"updated_at":244,"content_modified":245},"NCT07619482","Topical Insulin for Glaucoma (TING2)",[243],"Phase 1\u002FPhase 2","2026-08-26T02:18:01.700186Z","2026-06-04T01:30:07.904073Z",{"nct_id":247,"title":248,"phases":249,"status":236,"updated_at":250,"content_modified":251},"NCT06806332","Glaucoma Drop Aids Part 2",[],"2026-08-26T02:17:24.721169Z","2026-05-05T02:43:29.664897Z",{"nct_id":253,"title":254,"phases":255,"status":236,"updated_at":141,"content_modified":256},"NCT05992415","Know Your Pressures NYC",[],"2026-05-05T02:43:27.431745Z",{"nct_id":258,"title":259,"phases":260,"status":261,"updated_at":262,"content_modified":263},"NCT07327242","Effectiveness of a Large Language Model-Based Educational Tool on Visual Field Test Reliability in Glaucoma Patients",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:17.791881Z","2026-06-16T05:54:07.878869Z",{"nct_id":265,"title":266,"phases":267,"status":261,"updated_at":268,"content_modified":269},"NCT06693882","Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.",[],"2026-08-26T02:16:22.235886Z","2026-06-16T05:54:07.766457Z",{"nct_id":271,"title":272,"phases":273,"status":274,"updated_at":275,"content_modified":276},"NCT01957267","Functional and Structural Imaging for Glaucoma",[],"UNKNOWN","2026-08-03T03:33:53.839199Z","2026-05-13T02:55:06.080924Z",{"nct_id":278,"title":279,"phases":280,"status":274,"updated_at":281,"content_modified":282},"NCT01931904","Eye Pressure Lowering Surgery",[],"2026-08-03T03:09:55.663340Z","2026-05-13T02:55:06.080096Z",{"nct_id":284,"title":285,"phases":286,"status":274,"updated_at":287,"content_modified":288},"NCT06388096","CLAD Deconvolved PERG Responses in Glaucoma Patients",[],"2026-08-03T03:00:20.303350Z","2026-05-05T02:43:28.561672Z",[],[291,295,299,303,306,309,313,316,320],{"state":292,"count":293,"slug":294},"California",13,"california",{"state":296,"count":297,"slug":298},"New York",6,"new-york",{"state":300,"count":301,"slug":302},"Florida",5,"florida",{"state":304,"count":301,"slug":305},"Massachusetts","massachusetts",{"state":307,"count":301,"slug":308},"North Carolina","north-carolina",{"state":310,"count":311,"slug":312},"Maryland",4,"maryland",{"state":314,"count":311,"slug":315},"Texas","texas",{"state":317,"count":318,"slug":319},"Oregon",3,"oregon",{"state":321,"count":318,"slug":322},"Tennessee","tennessee"]